+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ophthalmic Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2032- Product Image
Ophthalmic Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2032- Product Image
Sale

Ophthalmic Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2032

  • Report

  • 400 Pages
  • August 2025
  • Region: Global
  • Infinium Global Research
  • ID: 6169875
UP TO OFF until Aug 31st 2026
Description Jump to:
The report on the global ophthalmic drugs market provides qualitative and quantitative analysis for the period from 2022-2032. The global ophthalmic drugs market was valued at USD 35.53 billion in 2023 and is expected to reach USD 73.99 billion in 2032, with a CAGR of 8.54% during the forecast period 2024-2032. The study on ophthalmic drugs market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2022-2032.

The report on ophthalmic drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global ophthalmic drugs market over the period of 2022-2032. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global ophthalmic drugs market over the period of 2022-2032. Further, the publisher's Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1. Drivers

  • The growing geriatric population is driving the ophthalmic drugs market.
  • Increasing awareness and early diagnosis of eye disorders are significantly driving the ophthalmic drugs market.

2. Restraints

  • The high cost of advanced ophthalmic drugs is restraining market growth.

3. Opportunities

  • Advancements in drug delivery systems are creating opportunities for the ophthalmic drugs market.

Research Methodology

A) Primary Research

The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global ophthalmic drugs market is segmented on the basis of drug class, disease type, product type, dosage form, route of administration, and drug type.

The Global Ophthalmic Drugs Market by Drug Class

  • Anti-allergy
  • Anti-inflammatory
  • Non-steroidal Drugs
  • Steroidal Drugs
  • Anti-VEGF Agents
  • Anti-glaucoma
  • Others

The Global Ophthalmic Drugs Market by Disease Type

  • Allergies
  • Infection
  • Glaucoma
  • Retinal Disorders
  • Uveitis
  • Dry Eye
  • Others

The Global Ophthalmic Drugs Market by Product Type

  • Prescription Drugs
  • Over-the-counter-drugs

The Global Ophthalmic Drugs Market by Dosage Form

  • Eye Solutions & Suspensions
  • Gels
  • Capsules & Tablets
  • Eye Drops
  • Ointments

The Global Ophthalmic Drugs Market by Route of Administration

  • Systematic
  • Topical
  • Local Ocular

The Global Ophthalmic Drugs Market by Drug Type

  • Branded Drugs
  • Generic Drugs

Company Profiles

The companies covered in the report include

  • Bausch + Lomb
  • F. Hoffmann-La Roche Ltd
  • AbbVie Inc.
  • Bayer AG
  • Regeneron Pharmaceuticals Inc.
  • Nicox
  • Alcon Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Santen Pharmaceutical Co., Ltd.

What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the ophthalmic drugs market.
2. Complete coverage of all the segments in the ophthalmic drugs market to analyze the trends, developments in the global market and forecast of market size up to 2032.
3. Comprehensive analysis of the companies operating in the global ophthalmic drugs market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. The publisher's Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Ophthalmic Drugs Market Highlights
2.2. Ophthalmic Drugs Market Projection
2.3. Ophthalmic Drugs Market Regional Highlights
Chapter 3. Global Ophthalmic Drugs Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Drug Class
3.4.2. Growth Matrix Analysis by Disease Type
3.4.3. Growth Matrix Analysis by Product Type
3.4.4. Growth Matrix Analysis by Dosage Form
3.4.5. Growth Matrix Analysis by Route of Administration
3.4.6. Growth Matrix Analysis by Drug Type
3.4.7. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Ophthalmic Drugs Market
Chapter 4. Ophthalmic Drugs Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Ophthalmic Drugs Market
5.2. Companies Profiles
5.2.1. Bausch + Lomb
5.2.2. F. Hoffmann-La Roche Ltd
5.2.3. AbbVie Inc.
5.2.4. Bayer AG
5.2.5. Regeneron Pharmaceuticals Inc.
5.2.6. Nicox
5.2.7. Alcon Inc.
5.2.8. Merck & Co., Inc.
5.2.9. Pfizer Inc.
5.2.10. Santen Pharmaceutical Co., Ltd.
Chapter 6. Global Ophthalmic Drugs Market by Drug Class
6.1. Anti-allergy
6.2. Anti-inflammatory
6.3. Non-steroidal Drugs
6.4. Steroidal Drugs
6.5. Anti-VEGF Agents
6.6. Anti-glaucoma
6.7. Others
Chapter 7. Global Ophthalmic Drugs Market by Disease Type
7.1. Allergies
7.2. Infection
7.3. Glaucoma
7.4. Retinal Disorders
7.5. Uveitis
7.6. Dry Eye
7.7. Others
Chapter 8. Global Ophthalmic Drugs Market by Product Type
8.1. Prescription Drugs
8.2. Over-the-counter-drugs
Chapter 9. Global Ophthalmic Drugs Market by Dosage Form
9.1. Eye Solutions & Suspensions
9.2. Gels
9.3. Capsules & Tablets
9.4. Eye Drops
9.5. Ointments
Chapter 10. Global Ophthalmic Drugs Market by Route of Administration
10.1. Systematic
10.2. Topical
10.3. Local Ocular
Chapter 11. Global Ophthalmic Drugs Market by Drug Type
11.1. Branded Drugs
11.2. Generic Drugs
Chapter 12. Global Ophthalmic Drugs Market by Region 2024-2032
12.1. North America
12.1.1. North America Ophthalmic Drugs Market by Drug Class
12.1.2. North America Ophthalmic Drugs Market by Disease Type
12.1.3. North America Ophthalmic Drugs Market by Product Type
12.1.4. North America Ophthalmic Drugs Market by Dosage Form
12.1.5. North America Ophthalmic Drugs Market by Route of Administration
12.1.6. North America Ophthalmic Drugs Market by Drug Type
12.1.7. North America Ophthalmic Drugs Market by Country
12.1.7.1. The U.S. Ophthalmic Drugs Market
12.1.7.1.1. The U.S. Ophthalmic Drugs Market by Drug Class
12.1.7.1.2. The U.S. Ophthalmic Drugs Market by Disease Type
12.1.7.1.3. The U.S. Ophthalmic Drugs Market by Product Type
12.1.7.1.4. The U.S. Ophthalmic Drugs Market by Dosage Form
12.1.7.1.5. The U.S. Ophthalmic Drugs Market by Route of Administration
12.1.7.1.6. The U.S. Ophthalmic Drugs Market by Drug Type
12.1.7.2. Canada Ophthalmic Drugs Market
12.1.7.2.1. Canada Ophthalmic Drugs Market by Drug Class
12.1.7.2.2. Canada Ophthalmic Drugs Market by Disease Type
12.1.7.2.3. Canada Ophthalmic Drugs Market by Product Type
12.1.7.2.4. Canada Ophthalmic Drugs Market by Dosage Form
12.1.7.2.5. Canada Ophthalmic Drugs Market by Route of Administration
12.1.7.2.6. Canada Ophthalmic Drugs Market by Drug Type
12.1.7.3. Mexico Ophthalmic Drugs Market
12.1.7.3.1. Mexico Ophthalmic Drugs Market by Drug Class
12.1.7.3.2. Mexico Ophthalmic Drugs Market by Disease Type
12.1.7.3.3. Mexico Ophthalmic Drugs Market by Product Type
12.1.7.3.4. Mexico Ophthalmic Drugs Market by Dosage Form
12.1.7.3.5. Mexico Ophthalmic Drugs Market by Route of Administration
12.1.7.3.6. Mexico Ophthalmic Drugs Market by Drug Type
12.2. Europe
12.2.1. Europe Ophthalmic Drugs Market by Drug Class
12.2.2. Europe Ophthalmic Drugs Market by Disease Type
12.2.3. Europe Ophthalmic Drugs Market by Product Type
12.2.4. Europe Ophthalmic Drugs Market by Dosage Form
12.2.5. Europe Ophthalmic Drugs Market by Route of Administration
12.2.6. Europe Ophthalmic Drugs Market by Drug Type
12.2.7. Europe Ophthalmic Drugs Market by Country
12.2.7.1. Germany Ophthalmic Drugs Market
12.2.7.1.1. Germany Ophthalmic Drugs Market by Drug Class
12.2.7.1.2. Germany Ophthalmic Drugs Market by Disease Type
12.2.7.1.3. Germany Ophthalmic Drugs Market by Product Type
12.2.7.1.4. Germany Ophthalmic Drugs Market by Dosage Form
12.2.7.1.5. Germany Ophthalmic Drugs Market by Route of Administration
12.2.7.1.6. Germany Ophthalmic Drugs Market by Drug Type
12.2.7.2. United Kingdom Ophthalmic Drugs Market
12.2.7.2.1. United Kingdom Ophthalmic Drugs Market by Drug Class
12.2.7.2.2. United Kingdom Ophthalmic Drugs Market by Disease Type
12.2.7.2.3. United Kingdom Ophthalmic Drugs Market by Product Type
12.2.7.2.4. United Kingdom Ophthalmic Drugs Market by Dosage Form
12.2.7.2.5. United Kingdom Ophthalmic Drugs Market by Route of Administration
12.2.7.2.6. United Kingdom Ophthalmic Drugs Market by Drug Type
12.2.7.3. France Ophthalmic Drugs Market
12.2.7.3.1. France Ophthalmic Drugs Market by Drug Class
12.2.7.3.2. France Ophthalmic Drugs Market by Disease Type
12.2.7.3.3. France Ophthalmic Drugs Market by Product Type
12.2.7.3.4. France Ophthalmic Drugs Market by Dosage Form
12.2.7.3.5. France Ophthalmic Drugs Market by Route of Administration
12.2.7.3.6. France Ophthalmic Drugs Market by Drug Type
12.2.7.4. Rest of Europe Ophthalmic Drugs Market
12.2.7.4.1. Rest of Europe Ophthalmic Drugs Market by Drug Class
12.2.7.4.2. Rest of Europe Ophthalmic Drugs Market by Disease Type
12.2.7.4.3. Rest of Europe Ophthalmic Drugs Market by Product Type
12.2.7.4.4. Rest of Europe Ophthalmic Drugs Market by Dosage Form
12.2.7.4.5. Rest of Europe Ophthalmic Drugs Market by Route of Administration
12.2.7.4.6. Rest of Europe Ophthalmic Drugs Market by Drug Type
12.3. Asia Pacific
12.3.1. Asia Pacific Ophthalmic Drugs Market by Drug Class
12.3.2. Asia Pacific Ophthalmic Drugs Market by Disease Type
12.3.3. Asia Pacific Ophthalmic Drugs Market by Product Type
12.3.4. Asia Pacific Ophthalmic Drugs Market by Dosage Form
12.3.5. Asia Pacific Ophthalmic Drugs Market by Route of Administration
12.3.6. Asia Pacific Ophthalmic Drugs Market by Drug Type
12.3.7. Asia Pacific Ophthalmic Drugs Market by Country
12.3.7.1. China Ophthalmic Drugs Market
12.3.7.1.1. China Ophthalmic Drugs Market by Drug Class
12.3.7.1.2. China Ophthalmic Drugs Market by Disease Type
12.3.7.1.3. China Ophthalmic Drugs Market by Product Type
12.3.7.1.4. China Ophthalmic Drugs Market by Dosage Form
12.3.7.1.5. China Ophthalmic Drugs Market by Route of Administration
12.3.7.1.6. China Ophthalmic Drugs Market by Drug Type
12.3.7.2. Japan Ophthalmic Drugs Market
12.3.7.2.1. Japan Ophthalmic Drugs Market by Drug Class
12.3.7.2.2. Japan Ophthalmic Drugs Market by Disease Type
12.3.7.2.3. Japan Ophthalmic Drugs Market by Product Type
12.3.7.2.4. Japan Ophthalmic Drugs Market by Dosage Form
12.3.7.2.5. Japan Ophthalmic Drugs Market by Route of Administration
12.3.7.2.6. Japan Ophthalmic Drugs Market by Drug Type
12.3.7.3. India Ophthalmic Drugs Market
12.3.7.3.1. India Ophthalmic Drugs Market by Drug Class
12.3.7.3.2. India Ophthalmic Drugs Market by Disease Type
12.3.7.3.3. India Ophthalmic Drugs Market by Product Type
12.3.7.3.4. India Ophthalmic Drugs Market by Dosage Form
12.3.7.3.5. India Ophthalmic Drugs Market by Route of Administration
12.3.7.3.6. India Ophthalmic Drugs Market by Drug Type
12.3.7.4. Rest of Asia-Pacific Ophthalmic Drugs Market
12.3.7.4.1. Rest of Asia-Pacific Ophthalmic Drugs Market by Drug Class
12.3.7.4.2. Rest of Asia-Pacific Ophthalmic Drugs Market by Disease Type
12.3.7.4.3. Rest of Asia-Pacific Ophthalmic Drugs Market by Product Type
12.3.7.4.4. Rest of Asia-Pacific Ophthalmic Drugs Market by Dosage Form
12.3.7.4.5. Rest of Asia-Pacific Ophthalmic Drugs Market by Route of Administration
12.3.7.4.6. Rest of Asia-Pacific Ophthalmic Drugs Market by Drug Type
12.4. RoW
12.4.1. RoW Ophthalmic Drugs Market by Drug Class
12.4.2. RoW Ophthalmic Drugs Market by Disease Type
12.4.3. RoW Ophthalmic Drugs Market by Product Type
12.4.4. RoW Ophthalmic Drugs Market by Dosage Form
12.4.5. RoW Ophthalmic Drugs Market by Route of Administration
12.4.6. RoW Ophthalmic Drugs Market by Drug Type
12.4.7. RoW Ophthalmic Drugs Market by Sub-region
12.4.7.1. Latin America Ophthalmic Drugs Market
12.4.7.1.1. Latin America Ophthalmic Drugs Market by Drug Class
12.4.7.1.2. Latin America Ophthalmic Drugs Market by Disease Type
12.4.7.1.3. Latin America Ophthalmic Drugs Market by Product Type
12.4.7.1.4. Latin America Ophthalmic Drugs Market by Dosage Form
12.4.7.1.5. Latin America Ophthalmic Drugs Market by Route of Administration
12.4.7.1.6. Latin America Ophthalmic Drugs Market by Drug Type
12.4.7.2. Middle East Ophthalmic Drugs Market
12.4.7.2.1. Middle East Ophthalmic Drugs Market by Drug Class
12.4.7.2.2. Middle East Ophthalmic Drugs Market by Disease Type
12.4.7.2.3. Middle East Ophthalmic Drugs Market by Product Type
12.4.7.2.4. Middle East Ophthalmic Drugs Market by Dosage Form
12.4.7.2.5. Middle East Ophthalmic Drugs Market by Route of Administration
12.4.7.2.6. Middle East Ophthalmic Drugs Market by Drug Type
12.4.7.3. Africa Ophthalmic Drugs Market
12.4.7.3.1. Africa Ophthalmic Drugs Market by Drug Class
12.4.7.3.2. Africa Ophthalmic Drugs Market by Disease Type
12.4.7.3.3. Africa Ophthalmic Drugs Market by Product Type
12.4.7.3.4. Africa Ophthalmic Drugs Market by Dosage Form
12.4.7.3.5. Africa Ophthalmic Drugs Market by Route of Administration
12.4.7.3.6. Africa Ophthalmic Drugs Market by Drug Type

Table Information

Report AttributeDetails
No. of Pages400
PublishedAugust 2025
Forecast Period2023 - 2032
Estimated Market Value ( USD ) in 2023 $ 35.53 Billion
Forecasted Market Value ( USD ) by 2032 $ 73.99 Billion
Compound Annual Growth Rate8.5%
Regions CoveredGlobal

Related Topics

Related Reports

Ophthalmic Drugs Market Size, Share & Trends Analysis Report by Drug Class (Steroidal Drugs, Anti-VEGF Agents), Disease, Dosage Form, Route of Administration, Product Type, Drug Type, and Region with Growth Forecasts, 2025-2030 - Product Image

Ophthalmic Drugs Market Size, Share & Trends Analysis Report by Drug Class (Steroidal Drugs, Anti-VEGF Agents), Disease, Dosage Form, Route of Administration, Product Type, Drug Type, and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Ophthalmic Drugs Market - Global Forecast 2025-2030 - Product Image

Ophthalmic Drugs Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Africa Ophthalmic Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032 - Product Image

Africa Ophthalmic Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032

  • Report
  • 100 Pages
  • Africa
From
Ophthalmic Drugs Market Report by Type, Drug Class, Indication, Dosage Form, Distribution Channel, and Region 2025-2033 - Product Image

Ophthalmic Drugs Market Report by Type, Drug Class, Indication, Dosage Form, Distribution Channel, and Region 2025-2033

  • Report
  • 150 Pages
  • Global
From
Vietnam Ophthalmic Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F - Product Image

Vietnam Ophthalmic Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F

  • Report
  • 83 Pages
  • Vietnam
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.